NACC-funded research

Since 2000, NACC has funded studies in Alzheimer’s disease and associated disorders. Awards are available only to investigators at the NIA-funded Alzheimer’s Disease Research Centers:

Collaborative Grants, made from 2000 to 2017, supported projects involving three or more collaborating Alzheimer’s Disease Research Centers. They were hypothesis-driven and addressed a scientific question outright or provided preliminary data for a subsequent R01 or other research grant.

Junior Investigator Grants, made from 2005 to 2017, were designed to support projects of ADRC researchers with the rank of assistant professor or below, and involved secondary analysis of data in the NACC UDS or Neuropathology Data Set.

New Investigator Grants, made from 2018 to the present, are designed to support projects of ADRC researchers with the rank of assistant professor or below; the use of NACC data is not required.


NACC research grants: Because of our funding cycle, NACC is not currently soliciting applications. ADRC-based researchers, please check back in summer 2021 for the new FOA for New Investigator projects.

Grants

Type
Grant #
Investigator
Title
Description
Date
New Investigator
2019-NI-12
Matthew Peters, MD
Traumatic brain injury and neuropsychiatric symptoms in individuals with dementia
The influence of traumatic brain injury (TBI) on Alzheimer’s disease and related dementias (ADRD) is increasingly established. It is also known that neuropsychiatric symptoms (NPS; e.g., depression, a
2019-2020
New Investigator
2019-NI-09
Alberto Serrano-Pozo, MD, PhD
A brain atlas of astrocytes and microglia in healthy aging and Alzheimer’s disease
Besides amyloid plaques and neurofibrillary tangles (NFTs), the Alzheimer’s disease (AD) brain exhibits proiminent astrocytic and microglial responses, which typically localize around the amyloid plaq
2019-2020
New Investigator
2019-NI-01
Tamar D. Gefen, PhD
Clinicopathologic substrates of dementia syndromes with FTLD-tau
Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disease found at autopsy that underlies a variety of clinical dementia syndromes, and is the second most common cause of dementia under
2019–2020
New Investigator
2018-NI-09
Corey T. McMillan, PhD
Primary age-related tauopathy: Epigenetic sources of resistance
Detailed neuropathological investigations suggest that nearly all adults >50 years of age have pathological evidence of neurofibrillary tau tangles (NFTs). As individuals age there is also an increase
2018-2019
New Investigator
2018-NI-08
Erin Boespflug, PhD
The intersection of amyloid and cerebrovascular pathology: The perivascular space
While the perivascular space (PVS) is at the intersection of demonstrated vascular and waste clearance mechanisms in Alzheimer's disease pathobiology, there presently are no data that directly address
2017–2018
New Investigator
2018-NI-03
Erik Johnson, MD, PhD
A proteomic network comparison of autosomal dominant and sporadic Alzheimer's disease
The biological mechanisms that lead to Alzheimer's disease (AD) are poorly understood. Much of our current understanding of AD mechanisms comes from the study of patients with autosomal dominant forms
2018-2019
Junior Investigator
2017-JI-06
Shoshana Bardach, PhD, University of Kentucky
Barriers to engagement in genetic research
Genetic discoveries have played, and continue to play, a critical role in our understanding of underlying pathological processes contributing to the development of degenerative dementias. With scienti
2017–2018
Junior Investigator
2017-JI-04
Miyeon Jung, PhD, Indiana University
Testing a model of cognitive function with APOE and BDNF genes and heart failure
Heart failure (HF) is a risk factor for poor cognitive function in domains of memory, executive function, and attention.1-3 HF often co-exists with Alzheimer disease (AD) and mild cognitive impairment
2017–2018
Junior Investigator
2016-JI-08
Mitsuru Shinohara, PhD
Effects of APOE genotype on longevity
Although the E4 allele of the apolipoprotein E (APOE4) and E2 allele (APOE2) are risk and protective factors, respectively, for Alzheimer’s disease, APOE is also associated with longevity; several cro
2016–2017
Junior Investigator
2016-JI-02
Aaron Koenig, MD
Lipophilic vs. hydrophilic statin exposure and post-mortem neuropathology
This project describes a proposed secondary analysis of NACC clinical and neuropathological data, designed to examine the relationship between lipophilic vs. hydrophilic statin exposure and post-morte
2016 – 2017
Junior Investigator
2016-JI-01
Rahul Desikan, MD, PhD
Predicting and quantifying Alzheimer’s disease risk
Late-onset Alzheimer’s disease (AD), the most common form of dementia, places a large emotional and economic burden on patients and society. With increasing health care expenditures among cognitively
2016–2017
Junior Investigator
2015-JI-05
Zheyu Wang, PhD
Prognostic ability of MRI biomarkers for AD early detection and monitoring
The applicant proposes to modify a novel statistical approach and develop a tailored methodology to study the recently available magnetic resonance imaging (MRI) data at the National Alzheimer’s Coord
2015–2016
Junior Investigator
2015-JI-01
Jonathan Graff-Radford, MD
Predictors of survival in Lewy body disease
Dementia with Lewy bodies (DLB) is the second most common cause of neurodegenerative dementia. Overall, DLB has a more aggressive course than Alzheimer’s dementia with shorter survival and earlier tim
2015–2016
Junior Investigator
2013-JI-03
Brittany Dugger, PhD
Relationship of cardiovascular risk factors to dementia subtypes
The increasing prevalence of cardiovascular risk factors such as obesity, hypertension, hypercholesterolemia and diabetes has become a major national health concern. These risk factors have a high pro
2013–2014
Junior Investigator
2013-JI-02
Yorghos Tripodis, PhD
Predicting the cognitive status of an aging population
Alzheimer’s Disease (AD), the most common form of dementia, is a significant cause of disability and mortality among the elderly. The latest figures show that 5.2 million people in the US, approximate
2013–2014
Junior Investigator
2012-JI-09
Joshua D. Grill, PhD
Assessing disease progression among Alzheimer’s disease patients with adult child study partners
Alzheimer’s disease (AD) invariably results in decline in cognitive ability, functional impairment and dependence. The individual providing care to the AD patient is critical to the patient’s overall
2012–2013
Junior Investigator
2012-JI-04
Maritza Dowling, MS, PhD, University of Wisconsin
Missing Data and the Identification of Optimal Predictors of Conversion to AD
A major interest in ongoing Alzheimer’s disease (AD) research is on identifying biomarkers that best predict which individuals will progress to AD. However, the accuracy in the identification of such
2012 – 2013
Junior Investigator
2011-JI-08
Katherine Gifford, PhD Boston University
Subjective Memory Complaint and Cognitive Aging
Alzheimer’s disease is a significant public health issue, affecting millions with billions of associated health care costs. Mild cognitive impairment (MCI) is purported to be a prodromal clinical phas
2011-2012
Junior Investigator
2011-JI-06
Heather Romero, PhD Duke University
Diagnostic Stability of Transitional States in a Diverse Population
This proposed Junior Investigator project will address the pressing need to develop diagnostically s table criteria for prodromal Alzheimer's disease (prAD) to aid in the identification of those indiv
2011-2012
Junior Investigator
2010-JI-05
Berneet Kaur, MD, Univ of California, Davis
The Influence of Smoking History on the Phenotype and Pathology of Dementia
The project will improve the understanding of the role of smoking history in the clinical phenotype of pathology of dementia. A rapidly aging population presents a number of challenges, one of which i
2010-2011
Junior Investigator
2010-JI-01
Patrick Brown, PhD, Columbia University
Common Functional Deficits in MCI and Dementia
The National Alzheimer'92s disease Coordinating Center (NACC) Junior Investigator Award proposal for the FY2010 focuses on the everyday functional abilities of individuals with cognitive impairment. T
2010-2011
Junior Investigator
2008-JI-02
Kathleen Hayden, PhD, Duke University
Identification of Cognitive Endophenotypes
Development of cognitive endophenotypes for genetic studies of Alzheimer's disease (AD) and other dementias is a growing area of research. Cognitive endophenotypes can be conceptualized as representin
2008-2009
Junior Investigator
2007-JI-02
Liana G. Apostolova, MD, University of California Los Angeles
Behavioral Reserve in MCI and AD
Behavioral symptoms are a prominent feature of Alzheimer’s disease (AD) and mild cognitive impairment (MCI). They occur concomitantly with cognitive decline and progress as the disease evolves. Recent
2007-2008
Junior Investigator
2007-JI-01
Ann M. Mayo, RN DNSc, University of California San Francisco
Determinants of Judgment and Problem Solving Among Patients with Dementia
As the population of older adults continues to increase, health care providers are encountering patients with dementia in ever increasing numbers. Many of these providers are concerned about their pat
2007-2008
Junior Investigator
2005-JI-11
Kala M. Mehta, DSc, University of California San Francisco
Ethnic Differences in Alzheimer’s Disease Survival and Pathology
Addressing the needs of diverse older adults with dementia is a public health issue of increasing importance as over three million dementia patients will be of minority ethnicity by 2050. A growing li
2005-2006
Page
of 3
Loading...

If you’re unable to find what you’re looking for, please don’t hesitate to contact us.

4311 – 11th Avenue NE, Suite 300, Seattle, WA 98105 |(206) 543-8637 | NACCmail@uw.edu

University of Washington

NACC is funded by the National Institute on Aging (U01 AG016976) and located in the Department of Epidemiology at the University of Washington School of Public Health, Walter A. Kukull, Ph.D., Director. © 2021 University of Washington